5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.

Lakkireddy, Dhanunjaya; R Ellis, Christopher; Thaler, David; Swarup, Vijendra; Gambhir, Alok; Hermiller, James; Erik Nielsen-Kudsk, Jens; Worthley, Stephen; Nair, Devi; Schmidt, Boris; Horton, Rodney; Gupta, Nigel; A Anderson, Jordan; Zhao, Hong; Alkhouli, Mohamad; Windecker, Stephan

doi:10.1016/j.jacc.2024.10.101

Public

5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.

Shared by NobleBlocks on Mar 25, 2025 • 12:00 AM UTC

Authors:

Dhanunjaya Lakkireddy

Christopher R Ellis

David Thaler

Abstract

BACKGROUND: The Amulet IDE trial (AMPLATZER Amulet Left Atrial Appendage Occluder [LAAO] Investigational Device Exemption [IDE] Trial) evaluated the safety and effectiveness of the Amulet occluder (Abbott) in patients with nonvalvular atrial fibrillation. The Amulet IDE trial is the largest randomiz...

Subject

Amulet

Watchman

atrial fibrillation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!